期刊文献+

甲乙煎对肝纤维化大鼠肝组织MMP2及TGFβ1表达的作用

The MMP2 and TGFβ1 expression changes of rat liver fibrosis tissue influenced by Jiayijian
下载PDF
导出
摘要 目的观察中药甲乙煎对实验性肝纤维化大鼠基质金属蛋白酶-2(MMP2)及转化生长因子1(TGFβ1)表达的作用。方法雄性清洁级Wister大鼠60只,随机分为正常对照组和肝纤维化模型组,运用二甲基亚硝胺对模型组大鼠诱导肝纤维化。4周后,将模型组大鼠随机分为模型对照组、甲乙煎高剂量[22g/(kg·d)]组和低剂量[5.5g/(kg·d)]组。对甲乙煎高、低剂量组大鼠分别给予甲乙煎灌胃,共治疗4周,处死全部大鼠。采用免疫组化法检测大鼠肝组织MMP2和TGFβ1的表达。结果经中药甲乙煎高、低剂量治疗后,甲乙煎高、低剂量组的大鼠肝细胞浆内TGFβ1的阳性表达与模型对照组比较,显著降低(P<0.05),其中甲乙煎高剂量组优于低剂量组(P<0.05);而甲乙煎高、低剂量组MMP2的表达较模型对照组无明显差异(P>0.05)。结论中药甲乙煎能下调实验性肝纤维化大鼠肝组织TGFβ1的表达,这是其抗肝纤维化的作用机制之一。 Objective To observe the effects of a traditional Chinese medicine Jiayijian on the matrix metalloproteinase-2 (MMP2) and transforming growth factor-betal (TGFβ1) expression in experimental hepatic fibrosis rats. Methods Sixty male Wister rats were randomly divided into normal control group and liver fibrosis model group. Dimethylnitrosamine(DMN) was administered to induce liver fibrosis in the model group, and rats in model group were randomly divided into model control group and Jiayijian treatment groups with high concentration (22g/[kg · d])and low concentration (5.5g/[kg · d]) 4 weeks after liver fibrosis had been induced. All rats were killed after 4 weeks intragastric administration of Jiayijian. The expression of MMP2 and TGFβ1 of rat liver tissue were detected by immunohistochemical method. Results The expression of TGFβin high and low concentrations of Jiayijian treatment groups was significantly lower than that in the model control group (P〈0. 05), and the expression of TGFβ1 in the high concentration of Jiayijian treatment group was significantly lower than the low concentration of Jiayijian treatment group (P〈0. 05), but there was no significant difference in the expression of MMP2 between high and low concentrations of Jiayijian treatment groups and the model control group (P〉0. 05). Conclusion Jiayijian can down-regulate the expression of TGFI31 of experimental hepatic fibrosis model rat's liver tissue, which is the one of the mechanisms of anti-liver-fibrosis.
出处 《中国感染控制杂志》 CAS 2011年第1期18-21,66,共5页 Chinese Journal of Infection Control
基金 邯郸市科学技术研究与发展计划项目(0923108133)
关键词 甲乙煎 肝纤维化 基质金属蛋白酶-2 转化生长因子1 大鼠 医学 中国传统 中药 Jiayijian liver fibrosis matrix metalloproteinase-2 transforming growth factor-1 rat medicine, Chinese traditional traditional Chinese medicine
  • 相关文献

参考文献6

二级参考文献23

  • 1钱绍诚.肝纤维化(肝硬化)的可逆性[J].中华消化杂志,1995,15(5):251-252. 被引量:134
  • 2宋家武,李绍白,张文英.血府逐瘀汤抗大鼠肝纤维化作用的研究[J].中西医结合肝病杂志,1997,7(1):38-40. 被引量:27
  • 3[1]Friedman SL. Molecular mechanisms of hepatic fibrosis and prin ciples of therapy[J]. J Gastroenterol, 1997,32(3):424-430.
  • 4[2]Lamireau T, Desmouliere A, Bioulac-Sage P,et al. Mechanisms of hepatic fibrogenesis[J]. Arch Pediatr, 2002,9 (4): 392-405.
  • 5[3]Housset C, Guechot J. Hepatic fibrosis: physiopathology and bi ological diagnosis[J]. Pathol Biol( Paris), 1999,47(9):886-894.
  • 6[4]Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy[J]. Clin Liver Dis, 2001,5(2) :315-334.
  • 7[5]Levy MT, McCaughan GW, Marinos G, et al. Intrahepatic expression of the hepatic stellate cell marker fibrohlast activation protein correlates with the degree of fibrosis in hepatitis C virus infection[J]. Liver ,2002,22(2):93 101.
  • 8[6]Liu P,Liu CH, Wang HN, et al. Effect of salvianolic acid Bon collagen production and mitogen-activated protein kinase activity in rat hepatic stellate cells[J]. Acta Pharmacol Sin ,2002,23(8):733-738.
  • 9[7]Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond[J]. Hepatology,2000,31(1):241-246.
  • 10[8]Inuzuka S, Ueno T, Torimura T, et al. The significance of co localization of plasminogen activator inhibitor-1 and vitronection in hepatic fibrosis[J]. Scand J Gastroenterol, 1997,32(10):1052-1060.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部